INCYTE CORPORATION vs Medpace Holdings, Inc., two Biotechnology stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where INCY and MEDP diverge most: on implied growth (priced in), INCY reads +3.0% and MEDP reads +32.9%; on p/b, INCY reads 4.24 and MEDP reads 37.12. The rest of the comparable metrics sit closer together. On valuation, today's INCY price has a different growth bar priced in than MEDP (+3.0% implied for INCY vs +32.9% for MEDP); the higher figure is the steeper assumption to clear, not a better or worse stock. What INCY's price implies is a bet that sits within the historical range (whole-company basis). What MEDP's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | INCY | MEDP |
|---|---|---|
| Price | $119.47 | $577.05 |
| Market cap | $23.9B | $16.1B |
| Sector | Biotechnology | Biotechnology |
| Stage | Growth | Growth |
| Implied growth (priced in) | +3.0% | +32.9% |
| P/E | 16.9 | 33.9 |
| P/B | 4.24 | 37.12 |
| P/S | 4.45 | 5.79 |
| EV/EBITDA | 12.5 | 25.6 |
| Revenue growth | +21.3% | +24.9% |
| Operating margin | 23.7% | 20.8% |
| Net margin | 26.7% | 17.7% |
| Return on equity | 25.5% | 113.3% |
| Return on assets | 19.5% | 23.9% |
| Return on invested capital | 25.3% | 107.6% |
| FCF yield | 6.3% | 4.4% |
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 3.68 | 0.73 |
| Altman Z (solvency) | 7.62 | 6.97 |
| Piotroski F (quality) | 6 / 9 | 8 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.